Seroprevalance of Brucella abortus in humans in Izmir Menemen and comparison of diagnostic tests; an experience between July 2012 and March 2022

dc.contributor.authorKaradam, Senem Yaman
dc.contributor.authorUzun, Berrin
dc.contributor.authorCoban, Berhan
dc.contributor.authorAtik, Tugba Kula
dc.date.accessioned2025-07-03T21:26:40Z
dc.date.issued2025
dc.departmentBalıkesir Üniversitesi
dc.description.abstractBrucellosis is still an important public health problem worldwide. This study was aimed to investigate the seroprevalence of brucellosis in our region, Menemen, I(center dot)zmir, a western Turkish province, retrospectively to determine whether variables such as sex, age and seasonal differences play a role in its seroprevalence, and to compare the performances of different serological tests used in diagnosis. Results of 5871 patient serums were included retrospectively in the study. Rose Bengal Test (RBT), Standard Tube Agglutination Test (Wright) (STAT) and Brucellacapt (BCAPT) tests were used. Analysis of the data was conducted in SPSS 25.0. While RBT was positive in 152 (2.8 %) of 5391 samples, STAT was positive in 247 (21.6 %) of the 1142 samples, and BCAPT was positive in 302 (21.3 %) of 1417 samples. Since BCAPT was accepted as the reference method, the sensitivity and specificity for the RBT were 36 % and 99 %, respectively, while the sensitivity and specificity for the STAT were 82 % and 98 %, respectively. The positivity was statistically significant in all tests. Highest intensity was in the 41-55 age group, followed by the >55 and 26-40 age groups, respectively. The positivity was statistically significantly higher in male patients than it was in female patients in all tests. When the distribution of the test positivity by months was examined, it was found to be statistically significantly higher in months between May and October. (Chi-Square X2<0.05). In conclusion, brucellosis is still an endemic problem in western Turkey. Thus, it would be appropriate to administer BCAPT and STAT primarily in the diagnosis of brucellosis.
dc.identifier.doi10.1016/j.diagmicrobio.2025.116899
dc.identifier.issn0732-8893
dc.identifier.issn1879-0070
dc.identifier.issue2
dc.identifier.pmid40472571
dc.identifier.scopus2-s2.0-105007062067
dc.identifier.scopusqualityQ2
dc.identifier.urihttps://doi.org/10.1016/j.diagmicrobio.2025.116899
dc.identifier.urihttps://hdl.handle.net/20.500.12462/21845
dc.identifier.volume113
dc.identifier.wosWOS:001506562800002
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherElsevier Science Inc
dc.relation.ispartofDiagnostic Microbiology and Infectious Disease
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WOS_20250703
dc.subjectBrucellosis
dc.subjectSeroprevalance
dc.subjectRose Bengal Test
dc.subjectStandard Tube Agglutination test
dc.subjectBrucellacapt
dc.titleSeroprevalance of Brucella abortus in humans in Izmir Menemen and comparison of diagnostic tests; an experience between July 2012 and March 2022
dc.typeArticle

Dosyalar